9/19/2025

More details about a possible deal in the media industry contributed to another leg up for Paramount and Warner Bros Discovery, while a report from a short seller sent shares of DexCom sharply lower.

Source: Yahoo

9/19/2025

Major stock indexes rise Friday as Wall Street awaits news from President Donald Trump's call with China's Xi Jinping.

Source: Yahoo

9/19/2025

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring device, questioned its accounting, and highlighted an executive exodus.

Source: Yahoo

9/19/2025

Major stock indexes turned mixed in the stock market today as Wall Street await news from President Trump's call with China's Xi Jinpingf

Source: Yahoo

9/19/2025

The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.

Source: Yahoo

9/19/2025

The Dow Jones index dropped Friday during the Trump-Xi phone call. Tesla stock rallied on an analyst upgrade.

Source: Yahoo

9/18/2025

Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s appearance.

Source: Yahoo

9/18/2025

Investors will have their first full day of marinating on the Fed cut, future outlook

Source: Yahoo

9/18/2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Source: Yahoo

9/17/2025

We came across a bullish thesis on DexCom, Inc. on Flyover Stocks Substack by Todd Wenning. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.’s share was trading at $76.22 as of September 12th. DXCM’s trailing and forward P/E were 53.68 and 29.41 respectively according to Yahoo Finance. DexCom (DXCM) is a leading […]

Source: Yahoo

9/17/2025

DexCom announced that Chairman and CEO Kevin R. Sayer has taken a temporary medical leave as of September 14, 2025, with President and COO Jacob S. Leach appointed interim CEO and Mark Foletta as interim chairman. At the European Association for the Study of Diabetes Annual Meeting on September 15, DexCom presented new clinical data highlighting the impact and cost-effectiveness of its glucose monitoring technology for diverse diabetes populations. We'll consider how the interim leadership...

Source: Yahoo

9/17/2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s return was flat while the S&P 500 climbed by 16.4%.

Source: Yahoo

9/16/2025

DexCom Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

9/16/2025

DexCom, Inc. (NASDAQ:DXCM) is one of the Best NASDAQ Stocks to Buy with Huge Upside Potential. Wall Street is bullish on DexCom, Inc. (NASDAQ:DXCM) after the company topped revenue and EPS estimates during its fiscal second quarter of 2025. The company posted $1.16 billion in revenue, up 15.21% year-over-year and ahead of consensus by $32.49 […]

Source: Yahoo

9/16/2025

Flavia Pease will take over as Insulet’s CFO on Sept. 30. Elsewhere, outgoing Dexcom CEO Kevin Sayer is taking a medical leave of absence.

Source: Yahoo

9/15/2025

Shares of medical device company DexCom (NASDAQ:DXCM) jumped 2.6% in the morning session after the company announced it would present new product features and positive clinical data at the European Association for the Study of Diabetes (EASD) 2025 conference.

Source: Yahoo

9/15/2025

VIENNA, September 15, 2025--DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for people with all types of diabetes at the upcoming 61st annual European Association for the Study of Diabetes (EASD) Conference.

Source: Yahoo

9/10/2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Source: Yahoo

9/10/2025

DexCom Inc. stock underperforms Wednesday when compared to competitors

Source: MarketWatch

9/10/2025

Get the latest insights from DexCom's 2025 strategy, CGM market growth, and upcoming

Source: SeekingAlpha